BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1862769)

  • 1. Preoperative chemoradiotherapy for adenocarcinoma of the pancreas. Rationale and technique.
    Evans DB; Byrd DR; Mansfield PF
    Am J Clin Oncol; 1991 Aug; 14(4):359-64. PubMed ID: 1862769
    [No Abstract]   [Full Text] [Related]  

  • 2. Preoperative chemoradiation for resectable and locally advanced adenocarcinoma of the pancreas.
    Evans DB
    J Gastrointest Surg; 2001; 5(1):2-5. PubMed ID: 11370617
    [No Abstract]   [Full Text] [Related]  

  • 3. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
    Evans DB; Rich TA; Byrd DR; Cleary KR; Connelly JH; Levin B; Charnsangavej C; Fenoglio CJ; Ames FC
    Arch Surg; 1992 Nov; 127(11):1335-9. PubMed ID: 1359851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival advantage of combined chemoradiotherapy compared with resection as the initial treatment of patients with regional pancreatic carcinoma. An outcomes trial.
    Snady H; Bruckner H; Cooperman A; Paradiso J; Kiefer L
    Cancer; 2000 Jul; 89(2):314-27. PubMed ID: 10918161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of exocrine carcinoma of the pancreas.
    Hoffman JP; Pendurthi TK; Johnson DE
    Cancer Treat Res; 1998; 98():65-82. PubMed ID: 10326665
    [No Abstract]   [Full Text] [Related]  

  • 6. The integration of chemotherapy into a combined modality approach for cancer treatment. VI. Pancreatic adenocarcinoma.
    Carter SK; Comis RL
    Cancer Treat Rev; 1975 Sep; 2(3):193-214. PubMed ID: 1104163
    [No Abstract]   [Full Text] [Related]  

  • 7. A single institutional experience with preoperative chemoradiotherapy for stage I-III pancreatic adenocarcinoma.
    Hoffman JP; Weese JL; Solin LJ; Agarwal P; Engstrom P; Scher R; Paul AR; Litwin S; Watts P; Eisenberg BL
    Am Surg; 1993 Nov; 59(11):772-80; discussion 780-1. PubMed ID: 7902052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic approach to pancreatic cancer.
    Barkin JS; Goldstein JA
    Gastroenterol Clin North Am; 1999 Sep; 28(3):709-22, xi. PubMed ID: 10503146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neoadjuvant chemoradiation for adenocarcinoma of the pancreas.
    Breslin TM; Janjan NA; Lee JE; Pisters PW; Wolff RA; Abbruzzese JL; Evans DB
    Front Biosci; 1998 Nov; 3():E193-203. PubMed ID: 9792895
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sequential and/or concurrent hypofractionated radiotherapy and concurrent chemotherapy in neoadjuvant treatment of advanced adenocarcinoma of the pancreas. Outcome and patterns of failure.
    Zimmermann FB; Schuhmacher C; Lersch C; Bernhardt B; Pickel P; Siewert JR; Molls M; Jeremic B
    Hepatogastroenterology; 2004; 51(60):1842-6. PubMed ID: 15532839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
    Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
    Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining venous involvement in borderline resectable pancreatic cancer.
    Chun YS; Milestone BN; Watson JC; Cohen SJ; Burtness B; Engstrom PF; Haluszka O; Tokar JL; Hall MJ; Denlinger CS; Astsaturov I; Hoffman JP
    Ann Surg Oncol; 2010 Nov; 17(11):2832-8. PubMed ID: 20725860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of preoperative radiochemotherapy in patients with locally advanced pancreatic carcinoma.
    Lind PA; Isaksson B; Almström M; Johnsson A; Albiin N; Byström P; Permert J
    Acta Oncol; 2008; 47(3):413-20. PubMed ID: 17882555
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative chemoradiation for adenocarcinoma of the pancreas and duodenum.
    Coia L; Hoffman J; Scher R; Weese J; Solin L; Weiner L; Eisenberg B; Paul A; Hanks G
    Int J Radiat Oncol Biol Phys; 1994 Aug; 30(1):161-7. PubMed ID: 8083109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinoma of the pancreas--bypass versus resection?
    Ong CL; Rauff A
    J R Coll Surg Edinb; 1993 Jun; 38(3):149-51. PubMed ID: 7687675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the pancreas.
    Helman C
    Ala J Med Sci; 1983 Oct; 20(4):402-4. PubMed ID: 6196985
    [No Abstract]   [Full Text] [Related]  

  • 17. Adenocarcinoma of the liver without a detectable primary.
    Abbruzzese JL; Carbone PP
    Hosp Pract (Off Ed); 1991 Dec; 26(12):61-8, 73, 77 passim. PubMed ID: 1744188
    [No Abstract]   [Full Text] [Related]  

  • 18. [Combined radiochemotherapy of an irresectable carcinoma of the pancreas].
    Schönekaes K; Rübe C; Sulkowski U; Preusser P; Prott FJ; Willich N
    Zentralbl Chir; 1998; 123(5):579-82. PubMed ID: 22462227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study.
    André T; Balosso J; Louvet C; Hannoun L; Houry S; Huguier M; Colonna M; Lotz JP; De Gramont A; Bellaïche A; Parc R; Touboul E; Izrael V
    Int J Radiat Oncol Biol Phys; 2000 Mar; 46(4):903-11. PubMed ID: 10705012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Combined locoregional therapeutic strategy in locally advanced cancers of the pancreas].
    Manivit P; Polo R
    Ann Chir; 1998; 52(1):100. PubMed ID: 9752423
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.